We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LLOY:LSELloyds Banking Group plc Analysis

Data as of 2026-05-20 - not real-time

£96.56

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Lloyds Banking Group (LLOY) is trading at £96.56, just above its 20‑day SMA (£97.27) and comfortably above the 200‑day SMA (£93.35), indicating a lingering bullish bias despite a bearish MACD signal. The stock’s PE ratio of 12x sits well below the industry average of 16.5x and the forward PE of 8x suggests significant valuation headroom, reinforced by an upside potential of roughly 19% to the consensus target of £115. Strong Q1 2026 results – a 33% jump in statutory pre‑tax profit to £2 bn and a 17% ROE – coupled with a solid dividend yield of 3.8% and a modest payout ratio of 44% underscore earnings momentum and dividend sustainability. Analyst sentiment is positive, with 18 analysts rating the stock as a “buy” and a mean target price of £114.8, while the Fear & Greed Index reads “Extreme Greed,” reflecting market optimism.
Risk considerations include elevated 30‑day volatility (≈36%) and a decreasing volume trend, but the low beta of 0.51 tempers market‑wide swings. Regulatory exposure inherent to UK banking and the modest geographic concentration present medium‑level risks, whereas liquidity remains adequate given a market cap of £56.2 bn. Overall, the blend of attractive valuation, robust earnings growth, and a resilient dividend profile makes LLOY a compelling addition for investors across horizons.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Price near short‑term support with bullish SMA alignment
  • Strong quarterly earnings beat and dividend yield
  • Technical upside to resistance around £103

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Analyst consensus target implying ~19% upside
  • Forward PE of 8x indicating cheap growth potential
  • Sustained dividend payout and improving ROE

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Stable cash generation and manageable debt profile
  • Low beta providing defensive characteristics
  • Consistent dividend policy supporting total return

Key Metrics & Analysis

Financial Health

Revenue Growth11.50%
Profit Margin26.50%
P/E Ratio12.1
ROE10.78%
ROA0.55%
P/B Ratio1.2
Industry P/E16.5

Technical Analysis

TrendBullish
RSI48.1
Support£93.22
Resistance£103.02
MA 20£97.27
MA 50£97.20
MA 200£93.35
MACDBearish
VolumeDecreasing
Fear & Greed Index89.39

Valuation

Target Price£114.83
Upside/Downside18.93%
GradeUndervalued
TypeBlend
Dividend Yield3.79%

Risk Assessment

Beta0.51
Volatility36.30%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.